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Editorial: A New Perspective
Laura Hinz BSc (Meds 2011)
A stack of Canadian Medical
Association Journals (CMAJ) sits on my
kitchen table. I have big plans to read and
understand each article, to expand my
knowledge, to feel like a real doctor. But
more often than not those CMAJs simply
serve as a place mat for the novel or
newspaper that I lay over top. It is always
with a twinge of guilt that I delay reading
these journals.
It feels like they are
something I should read, that I have a
responsibility to read. This guilt is made all
the more poignant by the question that
always seems to accompany my decision to
leave the CMAJ closed- why don’t I want to
read it? Didn’t I spend the better part of the
last decade doing everything I could to get
into medical school? Didn’t I experience an
almost embarrassing level of excitement
when that first issue was delivered to my
mailbox?
That question has nettled me all year
as the stack grew ever taller. But this
summer my clinical elective preceptor
helped me to answer that question. She said
that the CMAJ isn’t necessarily relevant to
me at this point in my training. We simply
haven’t learned enough to either completely
understand every article nor to find it always
interesting. Much like a book on skydiving
would be mildly intriguing to an earthbound reader, it doesn’t become riveting
until you’ve taken that first leap. This
summer, many of our classmates leapt for
the first time. We left behind our textbooks

and lectures and faced the real world of
medicine.
The Summer Supplement is a record
of those experiences in the real world. This
issue of the UWOMJ is considerably
different from the regular print issues. The
purpose of the articles in this issue is not just
to inform, but to inspire and celebrate.
These are the true experiences of our
classmates; they remind us of our own
summer experiences, encourage us to move
beyond the familiar, and commemorate the
successes of our peers. By capturing these
experiences in an article for the Summer
Supplement, we are able to leave a record of
all the things we accomplished this summer,
be it research, clinical electives, or travel.
In addition to different goals, the
perspective of this issue is remarkably
different. Normally the authors’ gaze is in
to the literature; the Summer Supplement
has challenged us to raise our eyes up from
our textbooks, beyond the walls of our
classrooms and to see how medicine exists
in the real world. This perspective is
simultaneously exciting, overwhelming, and
inspiring. Suddenly we saw that diseases
that were described in our notes happen to
real people, and it is now up to us to dredge
up all the facts that we painstakingly learned
throughout the year and apply them to actual
practice.
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A written discourse tells the world
how you want to be remembered. It is a
record of your thoughts and perceptions,
your level of knowledge, your interests.
That is what makes this issue of the
UWOMJ different from the regular print
issues and from publications like the CMAJ.
This compilation of articles is all about
perspective. Authors were encouraged to
write an article that would appeal to the
medical student, both in terms of knowledge
level and interest. While the goal was also
to
describe
common
presentations,
diagnostic tools, and treatments, the primary
aim of this issue was to create a record of
medicine through the eyes of the Classes of
2010 and 2011.

you for your own leap into the real world of
medicine.

It is immediately apparent that each
article in this collection has a slightly
different structure. The reason is that the
authors were encouraged to be creative.
Since perspective plays such a pivotal role in
this collection, each author was encouraged
to choose a style that worked for their topic,
their case, their style of writing.
Given this emphasis on perspective, I
hope this collection of articles will not suffer
the same fate as my CMAJs.
The
subsequent articles are each relevant to this
point of our education, simply by virtue of
the fact that they were written by members
of the intended audience. The diverse
compilation that follows will hopefully help
you to broaden your perspective, to consider
medicine as an entity outside of the
classroom, and to inspire you to approach
your studies in such a way that will prepare
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Right Total Shoulder Replacement with Reverse Delta
Prosthesis, Complicated by a Brachial Plexus Injury
Amin Madani, Hon. BSc. (Meds 2011), Dr. Richard M. Holtby, MD, MB, BS, FRCSC

Abstract/Introduction
When conventional total shoulder
replacements are not considered to be an
effective surgical management to
improve patients’ quality of life, a
reverse total shoulder arthroplasty is
considered. The reverse total shoulder
replacement is where a prosthesis with a
convex articular surface is fixed to the
lateral aspect of the glenoid, and a
prosthesis with a concave articular
surface is fixed to the proximal aspect of
the humerus (Figure 1).1 This procedure
was initially indicated for patients with
rotator cuff arthropathy, for whom a
traditional total shoulder replacement
has a relatively high rate of failure.1,2
Today, they are also indicated for
patients with failed arthroplasty, or for
selected patients with shoulder fractures
whose prosthesis has failed.3 Despite its
high success rate, this procedure is also

Figure 1. Delta prosthesis used for reverse total
shoulder arthroplasty.
http://www.jnjgateway.com/home.jhtml

It is
prone to complications.1,2,3,4
estimated that 1-4% of shoulder
arthroplasty cases produce neurologic
complications.1,2 In this type of patient
who has a history of rotator cuff
arthropathy and a full-thickness rotator
cuff tear that was repaired and
subsequently degenerated, it is shown
that a total shoulder arthroplasty with a
reverse prosthesis can be used to provide
improved function and quality of life. It
is furthermore shown that patient
recovery and functional outcome can be
complicated by radial nerve palsy.
Case
Mrs. W is a 74-year-old woman
seen in the clinic for assessment of her
right shoulder. She has a thirteen-year
history of pain, where she was diagnosed
with a rotator cuff tear and had surgical
repair nine years ago. Although she felt
this helped significantly, there was
gradual increase in pain and weakness of
the shoulder. Examination showed that
she was able to get her arm to 150o of
flexion with some catching and pain.
External rotation was 45o with internal
rotation to the thoracolumbar junction.
She had pain, crepitus coming from the
subacromial space, and significant
weakness of forward flexion. X-rays
were also done, which showed
degenerative
changes
at
the
glenohumeral joint with marked superior
migration of the humeral head with
respect to the glenoid fossa, consistent
with rotator cuff arthropathy.
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Rotator cuff arthropathy is
characterized by irreparable loss of the
rotator cuff, severe osteoarthritis of the
glenohumeral joint, pain, and minimal
function of the shoulder.1,2,3 It was felt
that a reverse prosthesis would not only
effectively help her pain and provide
more function, but unlike the traditional
shoulder replacements, would resist
superior translation of the humeral head
due to a lack of stability of the joint from
degeneration of the supraspinatus rotator
cuff muscle.
Surgical Technique
The shoulders were examined
with the patient under general
anaesthesia, where the range of motion
of the right side was noted to be suboptimal (Table 1).
Table 1. Pre-Operative Range of
Motion of the Right Shoulder
Forward Flexion
150o
Abduction
90o
External Rotation (with 0o 40o
abduction)
External Rotation (with 90o 40o
abduction)
Internal Rotation (with 90o 20o
abduction)
With the patient in the beach
position, draping was done to expose the
shoulder with the arm free, allowing the
surgeon and his assistants to manoeuvre
the arm in different positions. The
incision was a saber-cut incision, which
is made 4 cm from the superior border of
the anterior and middle deltoid fibers,
passing just above the acromioclavicular
joint, extending 5 cm inferiorly on the
posterior side and creating a reverse Ushape.1,2 A deep deltoid incision was
subsequently done to get access to the

joint. Operative findings included a
massive rotator cuff tear of the
supraspinatus estimated at 5 cm medial
to lateral and 5 cm anterior to posterior,
bone erosion and eburnation of bone on
the articular surface of the humeral head
and
glenoid
consistent
with
osteoarthritis,
degeneration
of
subscapularis and teres minor muscles,
and rupture of the long head of the
biceps tendon.
Initial neck cut was made
removing the head component at the
surgical neck of the humerus, providing
exposure of the glenoid with a fork
retractor. The capsule was then released
around the articular margins, and the
labrum and biceps tendon remnant
removed. Once the centre of the glenoid
was demarcated, a drill hole was made
into the glenoid medullary cavity. This
allowed the insertion of the glenosphere
reamer
and
metaglene
(glenoid
components of the prosthesis), which
were hammered into place, and fixated
with four screws.
After drilling a canal for the
humeral component’s stem, trial humeral
components were inserted to determine
the correct size of the prosthesis. After
appropriate trial reductions, the canal
was prepared for irrigation, filled with
cement, and the humeral stem cemented
into place.
Finally, the definitive
glenosphere and humeral polyethylene
components were inserted, and the joint
reduced, which showed stability with
good range of motion. After a routine
closure, the patient returned to the
recovery room with a simple blue sling
and in satisfactory condition. Ancef was
given as prophylactic antibiotic with two
doses given intra-operatively.
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Post-Operative Results and Discussion
Specimen sent with fragments of
bone and soft tissues from the joint, as
well as post-operative x-rays revealed no
apparent complications (Figure 2).
However, the day following surgery she
was noted to have a right finger and
wrist drop with numbness in the
posterior
arm,
despite
regaining
significant range of shoulder movement.
Examination revealed absent right
brachioradialis and triceps reflex with
normal biceps reflex. There was marked
weakness of right shoulder external
rotation and abduction, almost no triceps
function, no visible brachioradialis
function and only slight wrist extension
with total finger drop. Sensation to pin
was also reduced in the posterior hand,
forearm and upper arm.

cutaneous nerve of forearm normal.
Needle electrode examination revealed
marked and moderate denervations of
the infraspinatus and deltoid muscles,
respectively, and severe denervation
throughout the radial nerve distribution.
Although musculocutaneous, median
and ulnar nerve function were normal,
there was partial denervation in
suprascapular, axillary and mostly radial
nerve distribution. As there were some
surviving neurons, the nerves appeared
to be in continuity but with axonal
deterioration. It is likely that the lesion
was at the border of the teres muscle or
more proximally in the superior trunk.
With severe axonal loss in the radial
nerve distribution, recovery proceeded
slowly over a number of months with
appropriate physiotherapy, and the
patient eventually regained brachial
plexus function with total reinnervation.
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The Consequences of Poorly Controlled Diabetes in a Young
First Nations Man
Dax Biondi, BSc, MSc (Meds 2011) and Dr. Michael Kirlew, Northern Medical Practice,
Meno Ya Win Health Centre, Sioux Lookout
The consequences of poorly
controlled diabetes, including blindness and
renal failure, are exemplified in a young
man from an isolated Northwestern Ontario
community. The nurse in charge reported
during the summer of 2008 that 25% of
community members have diabetes. There
are many social and medical reasons for a
patient’s failure to control his or her blood
glucose. The claim that financial barriers
prevent First Nations people from eating a
diet that is high in fruits and vegetables,
complex carbohydrates and protein and low
in fat and sugar is addressed in the present
study. It is well known that morbidity can
result from poorly controlled diabetes;
Derek’s story sadly illustrates its devastating
toll.
Derek is 27 this year but as Dr.
Michael Kirlew mentioned, chronic poor
diabetes control has aged his blood vessels
to the equivalent of 47 years. Dr. Kirlew is a
family physician, one of several who has
provided care for Derek since he was
diagnosed with type II diabetes mellitus at
the age of 13. His sister, who also has
diabetes as do Derek’s mother and all his
maternal aunts, has taken care of him for the
last 3 years. Derek worked in renovations in
his community until diabetic complications
rendered him incapable. Clinic notes over
the past 3 years detail the toll that high blood

glucose has taken on Derek’s body. Despite
consistent medical advice and support,
Derek has failed to accept the invitation to
become involved in the management of his
disease. At such a young age, his condition
is now nearly palliative.
The backbone of type II diabetes
management is well-controlled blood
glucose;
maintaining
hemoglobin
glycosylation below 7% is protective against
microvascular complications1. It is not
surprising that it was difficult to convince a
rebellious 17 year old of the potential
consequences of his disease. As a teenager,
Derek felt fine and in the absence of
consistent family support, Derek did not
attend most of his diabetes education
classes. Free of charge, he was given the
opportunity to attend education camps and
counseling but he did not take advantage.
Five years later, at the age of 22, Derek’s
doctor dictated a letter to Derek’s boarding
school principal. His doctor urged the
principal to assist Derek with his blood
glucose control as its high levels where
likely impairing his ability to study. The
proportion of HbA1c that is glycosylated
reflects what a patient’s average blood
glucose has been over the proceeding 3
months2. Figure 1 illustrates that the
glycosylation of Derek’s HbA1c between
2006 and 2008 was consistently elevated.
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Fi
Fgure 1. Derek’s HbA1c measurements taken over 2 years demonstrate that his blood sugar was
consistently toxically elevated.
Pharmacotherapy of Derek’s disease
floundered. At 23 years, he was supposed to
be taking Glyburide, Metformin and insulin
to control his blood sugar. However, Derek
was forgetting to take his Glyburide and he
chose to stop taking his Metformin when an
increase in dose began to cause him
gastrointestinal upset. Shortly after, he
developed diabetic foot ulcers due to
neuropathy that rendered his feet less
sensitive. Yet, his feet were found to have
good pulses, colour and sensation and
fortunately, his ulcers were not infected. It
was assumed that his ulcers were due to
wearing work boots.

At 24 years, Derek began to
appreciate the gravity of his disease and was
willing to take insulin. However, 11 years of
poorly controlled diabetes had already
damaged his kidneys and urinalysis
indicated that there was protein in his urine.
He reported at that time that he did not drink
any alcohol nor take any illegal drugs.
Around 25 years, Derek discontinued
taking his insulin and Glyburide and made it
known he did not care to check his blood
sugar at home. This coincided with the onset
of infected foot ulcers for which treatment in
Sioux Lookout, a community 400km to the
south, had to be sought. Diabetes is a
UWOMJ 78(1) 2008 S8

vascular
disease
and
necessitates
cardiovascular protective pharmacotherapy.
Despite blood pressures as high as 165/102,
we cannot be certain this 25 year old was
taking his Ramipril regularly.
Almost 13 years of nearly
subclinical, consistently high blood glucose
levels began to show evidence of destruction
during Derek’s 26th year. At an appointment
in which his morning blood glucose was
found to be 15 mmol/L and post lunch, 1618, he stated that he had blurred vision and
bilateral decrease in sensation below the
knees. Despite these symptoms, he failed to
attend
an
appointment
with
an
ophthalmologist in the city of Winnipeg
because he did not qualify for an escort.
Given that escorts are an important part of
care for patients in isolated communities, the
government pays for the cost of
transportation for a friend or family member
to travel to one of the regional centres to
enable the patient to access required care.
Derek was frustrated that he did not qualify
for such a companion and for that reason, he
missed his appointment.
About a month after missing the
ophthalmology
appointment,
Derek
presented with a fixed dilated pupil due to a
dense vitreous hemorrhage of his right eye;
this caused neovascular glaucoma, which
rendered that eye blind. Shortly thereafter,
he developed bilateral diabetic peripheral
neuropathy and diffuse eczema on his lower
legs, presumably from venous stasis. In the
fall of that year, he began to experience
tunnel vision in his left eye and further tests
indicated proteinuria.

I had the opportunity to meet Derek
in his home clinic this past summer. At 27
years of age, he presented with leg pain that
was not responding to Tylenol Number 3.
He had a large ulcer on the dorsum of his
right foot, for which his doctor was
concerned about underlying osteomyelitis.
He had a deep vein saddle thrombosis,
which arched from his right femoral vein to
his left and he was in kidney failure. He was
blind and he could no longer walk.
To facilitate dialysis, Derek will
move to Thunder Bay in the near future. He
is aware of the irreversible toll that high
blood glucose has taken on his body and he
is trying to prepare himself for the
consequences.
Many social and medical factors
have contributed to Derek’s rapid and
debilitating course with diabetes. Genetic
predisposition has unarguably contributed to
Derek’s condition as have many social
predisposing factors. It is argued that the
high food costs in northern communities
may be one such social determinant of
health. How does the cost of food in Derek’s
isolated community compare to that in the
nearest regional centre?
The financial burden of eating well
in Derek’s community was documented by
the present author during August of 2008 at
one of the two local grocers, the Northern
store. It was found that it costs a person
about 2 times as much to stock his or her
fridge and pantry as someone living in Sioux
Lookout. Figure 2 shows that by food
group, most everything is double the price,
be it processed foods like fries and pizza
UWOMJ 78(1) 2008 S9

pops or fresh vegetables, whole grain breads
and

milk

Figure 2. The number of times groceries are more expensive in Derek’s community in
comparison to Sioux Lookout by food group.
This food price comparison is a look
at August food availability only and in other
months, supply may be less due to less food
being available in the off seasons or more
due to it being less expensive to bring in
food by ice road during the winter. It was
found that many fresh and healthy foods
were available for sale in town; physical
availability does not seem to be the cause of
poor diet. If expense were the main barrier
to eating a healthy and balanced diet then
price subsidization would be the answer to
preventing diabetes morbidity. It is likely

naïve, however, to deem that this would
resolve the problem. Skeptical of this
solution, I ponder the following questions,
“Is it not reasonable to assume that the lower
cost of living enjoyed by First Nations
people on reserves should off-set the high
cost of food? Are people making poor
choices in terms of how to prioritize their
financial resources rendering their diets
inadequate while fulfilling other desires?”
The reality of the price disparity
between the north and south cannot be
UWOMJ 78(1) 2008 S10

dismissed but I suspect it does not entirely
explain the high burden of diabetes and its
comorbidities. Interventions which have set
out to educate First Nations people on how
and why one must eat a balanced diet and
get adequate exercise have shown promise at
reducing the burden of obesity and diabetes3.
Perhaps these ingredients for health are met
with apathy stemming from complex social
issues including normalization of obesity4,
boredom, poverty, rebellion, and as Rock,
M. writes about, distress and societal
suffering?5
Investigation into the following
questions may shed further light on what
impairs some persons with diabetes from
maintaining low blood glucose: “What foods
do you usually buy at the grocery store?
What percentage of your money do you
spend on groceries each week? How many
dependents do you care for and how old are
they? What is the body mass index (BMI) of
your dependents? Do you think that healthy
foods at the store are too expensive? Do you
know the elements of a balanced diet?” Ho
et al. asked similar questions and concluded
that “Increasing knowledge and outcome
expectations
about
healthier
food
preparation and selection could help reduce
fat and sugar intake as well as increase fiber
intake.”6
The present discussion leaves many
questions in terms of the social
determinants, which led to Derek’s
condition. However, the case does give
striking support to the research on the
debilitating consequences of poorly
particularly
in
controlled
diabetes7,
genetically
susceptible
individuals8.

Whether or not the cost of groceries in
Derek’s community prohibited him from
following dietetic counsel is not known.
However, it is reasonable to conclude that
First Nations people in isolated communities
in Northwestern Ontario must allocate more
money for groceries than those in the south.
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Program: Medicine 5010 Non Credit
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Balloon brachytherapy in the treatment of invasive
ductal carcinoma of the breast in a rural setting
Kevin Mitchell, Hon. BSc (Meds 2011) and Valerie Jefford, MD
Case
A pleasant 61-year-old woman
presented to her family doctor after her
good friend was diagnosed with breast
cancer. She suffers from hypertension
and Raynaud’s, but denies any
cardiovascular disease or diabetes. At
the time of her surgical consultation, she
was taking Diovan 80/12.5mg, Adalat
30mg XL, and ASA 80mg OD. The
patient had an aunt who was diagnosed
with breast cancer in her sixties, with no
other significant family history. The
patient was morbidly obese, but
otherwise had an unremarkable physical

exam with the exception of a small
palpable lump in the lower outer
quadrant of the right breast, which was
firm and mobile. No lymphadenopathy
was detected. She underwent her first
mammogram, serving as her baseline
mammogram, and a small abnormality
was detected in the inferolateral aspect
of the right breast (Figure 1). A followup ultrasound and biopsy were
performed (Figure 2). Histological
examination of the biopsied tissue
indicated that the patient had invasive
ductal carcinoma of the right breast.

Figure 1. Mammogram of the right breast. White arrow indicates tumour location.
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Figure 2. Ultrasound of the right breast. White arrow indicates lesion.

The patient was counselled
regarding her surgical options. She was
offered a right partial mastectomy
followed by radiation treatment, or a
total mastectomy. She was also informed
about the sentinel lymph node biopsy
procedure, as well as the axillary lymph
node biopsy that may be necessary if the
sentinel lymph node biopsy was positive
for metastasis. The patient was also
educated on the sequence of events
following surgery, including some
routine investigations and a referral to
medical radiation oncology. The patient
decided to proceed with a partial
mastectomy,
understanding
that
radiation treatment must follow surgery.
The surgery was performed and the
tumour was determined to be 1.5
centimetres in diameter with a Grade I
Nottingham score. Sentinel lymph node
biopsy showed no metastasis.
The
distance of the closest margin of the
tumour was less than 1mm from normal
tissue, so the anterior margin was reexcised a few days later as a cautionary

measure. The final pathology report
showed fibrofatty tissue with a few small
ducts and one larger duct with
hyperplastic epithelium. Also present
were small clusters and tubules of bland
atypical cells. Haematoxylin and Eosin
stains were performed, as well as
Immunoperoxidase stains. The results
were compatible with low grade invasive
carcinoma of mammary ductal origin.
As an alternative to whole breast
radiation, the patient was informed of
balloon
brachytherapy
using
a
MammoSite balloon catheter. The
patient opted to undergo this procedure,
which entailed implanting a silicone
balloon connected to a catheter with an
inflation channel and a port for the
insertion of a high-dose brachytherapy
source. Radiation treatment for this type
of procedure generally consists of an
192
Ir source connected to a computercontrolled
high-dose-rate
remote
afterloader being inserted into the
balloon to deliver the prescribed dose of
radiation.1 The balloon catheter was
implanted into the patient and was
UWOMJ 78(1)2008 S14

inflated to its maximum capacity of
70mL with normal saline (Figure 3). The
surgery was performed at Western
Memorial Regional Hospital in Corner
Brook, Newfoundland, after which the
patient was transferred to the Health
Sciences Centre in St. John’s,
Newfoundland to receive a 5-day course
of radiation.

Figure 3. Post-operative CT scan of
right breast. White arrow indicates
brachytherapy balloon filled with normal
saline.
Discussion
Breast conservation therapy (BCT)
is an attractive treatment option for
patients with Stage I and II breast
cancer.2 BCT for early-stage breast
cancer involves the surgical removal of
the tumour followed by whole-breast
radiation.3 Long-term studies have
indicated that disease-free survival for
breast conservation therapy is similar
when compared to mastectomy.4,5 Based
on the cosmetic advantages and the

similar
survival
rates,
balloon
brachytherapy is an ideal treatment
option for patients wishing to avoid a
total mastectomy.
Patient selection criteria for
balloon brachytherapy as determined by
the American Society of Breast Surgeons
is patient age of 50 years or over,
invasive ductal carcinoma or ductal
carcinoma in situ, 2 cm tumour size,
negative microscopic margins with
surgical margins of excision of at least 2
mm, and N0 nodal status.1
In comparison to multi-catheter
brachytherapy, balloon brachytherapy
has several advantages.
Balloon
brachytherapy has been shown to be
superior to
interstitial high-dose
radiation brachytherapy in planning
target volume coverage.6 While both
therapies deliver high-dose radiation to
the patient in one week or less,
interstitial implants using multiple
catheters require additional expertise and
training.
Furthermore,
numerous
puncture sites are required for multicatheter brachytherapy, which can lead
to suboptimal cosmetic outcome and
infection.1
Balloon brachytherapy confines
radiation treatment to a limited volume
of breast tissue adjacent to the
lumpectomy cavity, which allows for a
higher dose of radiation per fraction,
decreasing treatment time.6 This makes
balloon brachytherapy an ideal treatment
option for patients from smaller
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communities. Conventional radiation
therapy following lumpectomy generally
takes 5 weeks to complete. For a patient
from a small town, this requires
undergoing daily radiation treatments in
a larger centre, potentially far away from
the patient’s place of residence. The
patient treated in this case resided over
600 km from the closest breast cancer
radiation treatment centre. Balloon
brachytherapy enabled the patient to
undergo a 5-day course of radiation
treatment as an alternative to 5 weeks of
radiation. In the context of the patient’s
illness experience, instead of having to
relocate to St. John’s, Newfoundland for
5 weeks, the patient was able to stay in
St. John’s for 5 days to complete her
radiation treatment and then return
home. Ultimately, this treatment option
allows for less time away from home and
a higher quality of life during treatment.
Conclusion
BCT with balloon brachytherapy
is an excellent treatment option for
patients fitting the selection criteria. This
therapy has very good cosmetic results
along with a reduced post-operative
radiation
treatment
time
while
maintaining the efficacy of a total
mastectomy. This allows for patients to
receive treatment while limiting the
interference in their everyday lives that
comes with 5-week whole-breast
radiation courses, resulting in an
increased quality of life. Where patients
from rural communities once may have
chosen a total mastectomy instead of

undergoing BCT due to the five weeks
of radiation, balloon brachytherapy and
the associated reduced treatment time
enables these patients to opt for BCT in
lieu of a total mastectomy.
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Peripheral Vascular Disease: A Tale of Ulcers and Cans of
Tomatoes
Laura Hinz BSc (Meds 2011), Dr. Laura Heemskerk, MD and Dr. Ernie Janzen, MD
Case
This is a case of peripheral vascular
disease, but it is not a story about a toe.
Rather, it is a story about a can of tomatoes.
A can that is perched precariously on the
counter in the home of a 92-year old woman,
Mrs. S. Six months ago, that can fell onto
the first toe of her left foot. Five months
ago, Mrs. S began to experience increasing
discomfort in that toe and began a home
treatment regimen of Polysporin (bacitracin
and polymyxin) and Bactroban.
Mrs. S is accustomed to managing
her own health concerns, as she is currently
on
medication
for
hypothyroidism
(Synthroid), hypertension (Adalat and
Inhibace) and atrial fibrillation (Coumadin).
She has peripheral vascular disease that was
treated
with
bilateral
surgical
revascularization twenty years ago yet she
has absent popliteal and pedal pulses. Her
medical history was notable for migraines,
angina, varicosities, macular degeneration,
and profound hearing loss in the left ear.
When it became clear that her home
treatments were making slow progress, Mrs.
S presented to her internist’s office. The can
of tomatoes had done considerable damagethe sole of the left great hallux was marked
by a 1.5 cm ulceration that extended to the
bone. There was no necrosis or obvious
signs of infection except a slight yellow

drainage. Mrs. S needed to wear her shoes
at all times in order to maintain her balancemeaning the wound was under constant
pressure.
The internist informed Mrs. S that in
order to prevent amputation of the toe and
possibly the foot, she would need to be
admitted to hospital, a treatment plan that
was less than appealing to Mrs. S. She had a
home and a dog to care for and was reluctant
to relinquish her independence, yet she
eventually consented to enter the hospital.
The wound was diagnosed as an ischaemic
ulcer secondary to peripheral vascular
disease and a plastic surgery consult was
ordered. The x-ray revealed no fractures or
dislocations but
significant
vascular
calcification between the first and second
metatarsals. She was treated with a silver
sulfadiazine
dressing
(Flamazine),
Amoxicillin and Clavulin orally. Mrs. S
spent 27 days in hospital and was discharged
with forefoot offloading shoes.
Peripheral Vascular Disease:
Manifestations
Peripheral vascular disease is an
occlusive disorder caused by atherosclerosis.
More than 50% of patients are asymptomatic
whereas others present with claudication,
ischaemic ulcers, or gangrene when blood
supply is unable to meet metabolic demand
(Figure 1).1,2 PVD is more common in the
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elderly, with a 5.6% prevalence in the 38-59
age range versus 26% in those 81 and older.1
A study in Wound Repair and Regeneration
found that 26.2% of patients admitted from
nursing homes had pressure ulcers compared
to only 4.8% from other living situations.3
Ulcers are especially prevalent among
patients with diabetes mellitus, with up to
25% of diabetics developing an ulcer.4 Risk
factors for PVD include smoking,

hypothyroidism, diabetes, hypertension,
dyslipidemia,
elevated
plasma
1
homocysteine.
Besides endangering the
viability of peripheral tissue, PVD can also
increase the risk of adverse cardiovascular
events such as MI or stroke.1
PVD most often manifests as leg
ulcers, which can be classified as arterial,
venous,
or
neuropathic:5

Figure 1. Comparison of the manifestations of leg ulcers in terms of location, colour of wound,
presence of pain/pulse/sensation, and subclassification.1,2
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PVD: Diagnosis

PVD: Treatment

The single most useful tool in
assessing the manifestations of PVD,
according to the Ontario Venous Leg Ulcer
Community Care Protocol, is the anklebrachial pressure index (ABPI), a ratio of
the blood pressure in the arm relative to the
leg.6 Normal ABPI is 0.9 to 1.2, venous
ulcers have an ABPI greater than 0.8, mixed
ulcers between 0.5 and 0.8 and arterial
ulcers less than 0.5.6,1 This distinction
determines management as arterial ulcers
often require referral to a vascular specialist
while venous ulcers may be treated with
compression
bandages
and
topical
6
antibiotics. Also helpful in the diagnosis of
PVD are segmental Doppler pressures,
volume plethysmography, duplex imaging,
magnetic resonance angiography, and
contrast angiography.5

To promote healing, the ulcerated
area must be offloaded.
This can be
achieved through footwear modification or
activity restriction.8 The challenge is to
remove pressure from the wound without
compromising balance.
Options for
footwear modification include insoles
(Sorbothane or polyurethane), plantar
moulding, forefoot offloading shoes, and
rocker bottom shoes.
However these
modifications have been shown to reduce
activity level by up to 90%.8

As in the case of Mrs. S, the
manifestations are easy to diagnose once
they are observed but the challenge is often
the identification step. Despite frequent
access to quality care, ulcers may go
unnoticed for a myriad of reasons- they are
overshadowed by more pressing health
concerns or they are unnoticed even by the
patient (such as in cases of diabetic
neuropathy). In a study of patients receiving
home health care, 7-12% had pressure
ulcers.7
This study recommended an
educational program for home healthcare
workers in order to promote early
recognition of ulcers.

Treatment of leg ulcers often
involves topical or oral antibiotics with more
severe
cases
requiring
amputation.
Treatment of PVD focuses on control of risk
factors- smoking cessation, diabetic control,
statins for dyslipidemia, antiplatelet therapy,
ACE inhibitors, and exercise.1
Discussion
The diagnosis and treatment in this
case was fairly straight forward- a known
history of peripheral vascular disease, a clear
mechanism of injury, recognition of the need
to remove sources of pressure to promote
healing and the use of antibiotics to prevent
infection. The unique features of the case
pertain to the can of tomatoes.
Two immediate questions are why
the injury occurred in the first place and why
it went untreated for six months. The
answer to the first question may be
attributed to advances in internal medicine.
According to Dr. Hazel, a plastic surgeon in
Lethbridge, Alberta, “internal medicine has
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become too good- people no longer die of
their organ problems; now we have to be
aware of peripheral issues.” In the USA,
60,000 patients die of peripheral ulcer
complications annually.7 Mrs. S had a past
history riddled with internal complaints but
all were well controlled with medication,
thus allowing her to remain in her own home
at the age of 92. So while the internists may
congratulate themselves on the arsenal of
effective medications at their disposal, they
must be aware of the new Frankenstein their
success has created. Increasing attention
must be paid to issues outside of the head
and thorax.
The Ontario Leg Ulcer
Community Care Protocol suggests that
monitoring is the single best intervention in
regards to peripheral ulcers.9 Simple tests
such as the ankle-brachial index are quick
and easy to complete at each visit and when
combined with a physical exam that extends
to each digit may lead to earlier diagnosis of
arterial ulcers. Care of PVD and subsequent
ulcers
requires
a
multidisciplinary
10
approach.
The response to the second question
is twofold- the ulcer was not noted because
Mrs. S’s caretakers and physicians did not
see it and because she chose not to display
it. Why did she choose to conceal a bonedepth ulceration? It is likely because she
knew that in hospital tomatoes came not in
cans, but only in the plastic compartment of
her meal tray. The can represented her
independence, her ability to care for herself.
This is in contrast to what Morgan and
Moffatt described as the “social ulcer”- a
wound that the patient hopes will not heal in

order to maintain contact with the medical
profession and thus the outside world.11 The
complication in this case was not the
diagnosis or treatment of the ulcer, but the
struggle of an elderly woman to choose
between staying in a place where tomatoes
came in cans and entering a place that would
promote the viability of her toe. A study in
International Wound Care identified
practitioner focus on the wound rather than
the whole person as one of the greatest
barriers to ulcer care.11
Struggles such as this take time to
contemplate- time that most internists do not
have. Enter the medical student. We often
worry that we don’t have the knowledge or
experience to effectively treat patients.12
But we are also lacking something else that
serves in our favour- pagers. A medical
student is at liberty to spend an hour with
patients like Mrs. S, working out details
such as who would care for her dog.2 So the
next time you feel under qualified or
obtrusive as a medical student, remember
that both the physician and the patient will
be grateful for your pager-less ability to
acknowledge the importance of the can of
tomatoes, not just the ulcer.
References
1. Aronow WS. Management of peripheral
arterial disease of the lower extremities
in elderly patients. J Gerontol A Biol Sci
Med Sci. 2004; 59(2): 172-7.
2. Haffling AC, Hakansson A. Patients
consulting with students in general
practice: Survey of patients’ satisfaction
with their role in teaching. Medical
Teacher. 2008; 20:1-8.
UWOMJ 78(1) 2008 S21

3. Keelaghan E, Margolis D, Zhan M,
Baumgarten M. Prevalence of pressure
ulcers on hospital admission among
nursing home residents transferred from
hospital.
Wound
Repair
and
Regeneration. 2008; 16(3): 331-6.
4. Bentley J, Foster A. Multidisciplinary
management of the diabetic foot ulcer.
British Journal of Community Nursing.
2007; 12(12): S6, S8, S10.
5. Neschis DG, Golden MA. Clinical
manifestations and evaluation of chronic
critical limb ischaemia. UpToDate. Jan
2008.
6. Graham ID, Harrison MB, Lorimer K,
Piercianowski T, Friedberg E, Buchanan
M, Harris C. Adapting national and
international
leg
ulcer
practice
guidelines for local use: the Ontario Leg
Ulcer Community Care Protocol.
Advanced Skin Wound Care. 2005;
18(6):307-18.
7. Naber JL, Perlow M. Pressure ulcers
and the home health aide: evaluation of
an educational program.
Home
Healthcare Nurse. 2008; 26(5): 269-72.
8. Van Deursen R.
Footwear for the
neuropathic patient: offloading and
stability. Diabetes Metab Res Rev 2008;
24(Suppl 1): S96–S100.
9. Harrison MB, Mackey M, Friedberg E.
Pressure ulcer monitoring: a process of
evidence-based practice, quality, and
research. Joint Commission Journal on
Quality and Patient Safety. 2008;
34(6):355-9.
10. Levine JM, Savino F, Peterson M, Wolf
CR. Risk management for pressure
ulcers: when the family shows up with a
camera.
Journal of the American
Medical Directors Association. 2008;
9(5): 360-363.
11. Morgan PA, Moffatt CJ. Non-healing
leg ulcers and the nurse-patient
relationship.
Part 2: the nurse’s

perspective.
International Wound
Journal. 2008; 5(2): 332-339.
12. Haidet P, Stein HF. The role of the
student-teacher relationship in the
formation of physicians: the hidden
curriculum as process.
Journal of
General Internal Medicine.
2006;
21(S1): S16-20.
Inspiration
Location: Lethbridge Regional Hospital in
Lethbridge, AB
Program: One-month Internal Medicine
Observership through the Alberta Rural
Physician Action Plan

UWOMJ 78(1) 2008 S22

Coronary Artery Disease: Medical Management vs.
Percutaneous Coronary Intervention
Samir Raza, BESc Candidate (Meds 2010) and Jaffer Syed, MD, FRCP
Case
Mrs.G, a 55 year old female,
presented to her family doctor one year
ago with chest pain on exertion. The
pain was described as sharp in nature,
radiating to both arms and was not
accompanied by shortness of breath.
Symptoms initially appeared following
weight lifting at the gym. Currently, she
is able to carry out all activities of daily
living (ADLs) without limitation. Chest
pain is elicited by brisk walking or
carrying groceries up stairs, placing her
in Canadian Cardiovascular Society
(CCS) class I-II. She has a blood
pressure of 130/72, heart rate of 60, and
BMI of 27. She is a non-smoker with
well controlled dyslipidemia. Upon
investigation, MIBI stress testing
demonstrated moderate-sized inferior
wall ischaemia consistent with right
coronary artery (RCA) disease. Her
current medications include ECASA,
atorvastatin, ezetimibe (antilipemic),
bisprolol (beta-blocker), perindopril
(ACE inhibitor), and a nitroglycerine
spray. Following discussion with the
patient, it was decided that coronary
angiography and possible percutaneous
coronary intervention (PCI) was not
indicated at this time as symptoms were
mild and a satisfactory quality of life
was maintained. Mrs.G was encouraged

to use her nitroglycerine
prophylactically.

spray

Discussion
Coronary Artery disease (CAD) is
the leading cause of death in the
developed world with 1/3 of all deaths
attributed to CAD1. Blood flow through
the coronary arteries becomes impaired
by two mechanisms:
1. Stenotic lesions
2. Endothelial dysfunction
Fixed atherosclerotic plaques cause a
narrowing of the coronary arteries. This
stenosis causes an increase in vascular
resistance and thus, a decrease in
coronary blood flow. Atherosclerotic
plaques may also be associated with
endothelial dysfunction and paradoxical
coronary vasoconstriction. During times
of physical or emotional stress, a
mismatch in myocardial oxygen supply
and demand (myocardial ischemia) may
result from both epicardial stenosis and
endothelial dysfunction. Myocardial
ischemia often (but not universally)
manifests clinically as angina pectoris 2.
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Signs and Symptoms
Angina pectoris is the hallmark
symptom of CAD. It is frequently
described by patients as a diffuse
retrosternal tightness or pressure in the
chest lasting for a few minutes. In
women it is not uncommon for the pain
to be described as sharp. It commonly
radiates to the shoulders and arms.
Patients often hold a clenched fist over
their chest to describe the pain, this is
known as “Levine’s sign”. Anginal
symptoms
are
elicited
by
physical/emotional stress, eating, and
exposure to cold3.
Diagnosis
In addition to the clinical findings
mentioned, there are a variety of tests
available to aid in the diagnosis of CAD.
Table 1 lists the different modalities.
Table 1. Diagnostic studies and corresponding
positive findings for CAD4.
Modality
Finding
ECG / Exercise
Stress Test

Nuclear
studies
(MIBI scan)

Exercise
Echocardiography
Coronary
Angiography

ST depression, T wave inversion
Poor radionuclide accumulation in
ischemic areas. Radionuclide
accumulates in proportion to
degree of perfusion of viable
myocardial cells.
Stress-induced regional wallmotion abnormality
Stenotic coronary artery seen on
fluoroscopy during injection of
contrast agent

CAD can lead to and/or exacerbate
heart failure. The New York Heart
Association
(NYHA)
Functional

Classification system is commonly used
to classify the severity of heart failure.
This classification system is based upon
the degree of physical limitation
experienced by the patient. Table 2 lists
the NYHA system5.
Table 2. NYHA Functional Classification
system for heart failure5.
Class
Definition
Patients with no limitation of
activities; they suffer no symptoms
I
from ordinary activities
Patients with slight, mild limitation of
activity, they are comfortable with rest
II
or mild exertion
Patients with marked limitation of
activity; they are comfortable only at
III
rest
Patients who should be at complete
rest, confined to bed or chair; any
IV
physical activity brings discomfort and
symptoms occur at rest

Medical Management vs. PCI
Treatment of CAD involves medical
management to control symptoms of
ischemia as well as control of coronary
risk
factors,
and
occasionally
revascularization (PCI or CABG). The
goals of treatment are threefold:
1. Decrease frequency and severity
of anginal episodes
2. Prevent myocardial infarction
3. Prolong survival
Medical management of ischemic
symptoms of CAD often involves a
combination of three anti-ischemic
medications: nitrates, beta blockers, and
calcium channel blockers4. Nitrates are
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primarily used prophylactically and as
needed for acute symptom relief. For
secondary prevention purposes, ASA,
statins,
and
ACE-inhibitors
or
angiotensin-receptor blockers (ARB) are
strongly recommended.
Revascularization involves either
percutaneous coronary intervention
(PCI) or coronary artery bypass grafting
(CABG). Traditionally, PCI has been
indicated for discrete single or double
vessel disease whereas CABG has been
the mainstay of treatment for left-main
or multi-vessel disease6. However,
advances in interventional techniques
and the advent of drug eluting stents
have resulted in increasing numbers of
patients with complex, multi-vessel and
left main disease being treated via PCI7.
Current literature suggests that PCI in
stable CAD offers improved symptom
relief as compared to medical therapy
alone, but it does not prolong survival8.
In the case of Mrs.G, her nuclear MIBI
findings suggested single vessel CAD,
and PCI could potentially be appropriate
for relief of unacceptable symptoms.
However, given the additional risks
associated with any invasive procedure,
angiography
and
revascularization
(CABG or PCI) is generally indicated in
only three situations:
1. Medical
therapy
has
not
adequately improved patient’s
symptoms
2. Unacceptable adverse effects
associated with medication

3. Patients who are suspected to
have high-risk CAD4
The cornerstone of management of
CAD is aggressive medical therapy.
When this fails, or non-invasive testing
suggests a high-risk pattern of CAD,
coronary angiography is indicated.
Angiographic findings, patient age, comorbidities, and patient preferences, are
some main factors considered when
deciding upon the appropriate route of
revascularization.
Conclusion
Mrs.G presented with a one year
history of chronic stable angina.
Symptoms were well-controlled on
medical therapy alone, and non-invasive
testing did not suggest a prognostically
significant pattern of CAD. Based on
these considerations, continuance of
medical therapy was recommended.
Prophylactic use of nitroglycerin spray
was encouraged, as was continued
coronary risk factor reduction.
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Adolescent hallux valgus; a novel case report and
review
Anthony Main, BSc (Meds 2011) and Peter Clark, MD, FRCSC
Case
A 12-year-old female presented
with a four year history of bilateral
hallux valgus (HV) which caused her no
pain, but a significant cosmetic
deformity as seen in figure 1. Her
condition
had
been
treated
conservatively by a podiatrist for 4 years
with splinting, toe gel spacers, and use

of anti-pronation running shoes.
However, her HV deformity showed no
improvement
with
conservative
management. Her parents, concerned
that the deformity would become more
severe over time, consulted their family
physician,
who
arranged
for
radiographic imaging studies and
referred her for an orthopedic consult for
surgical management.

Figure 1. Juvenile hallux valgus deformity of right foot in an asymptomatic 12-year-old
girl. Deformity is bilateral with a second hallux valgus deformity on the left foot.
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On examination, the patient was
found to have a 20° HV angle pes planus
and short first metatarsal. Her medical
history was non-contributory. She was
born at term by cesarean section and had
a fraternal twin brother.
Bilateral
foot
radiographic
examination was undertaken with AP,
lateral and oblique views of the patients
foot. The patient was found to be
skeletally immature with open physes,

and the HV deformity was worse on the
right than the left. Radiographs also
revealed a congenitally short first
metatarsal, HV angle of 20° and an
abnormal metatarsophalangeal (MTP)
joint which was cone shaped with a ring
shaped epiphysis at the base of the
proximal phalanx, as seen in Figures 2
and 3. To our knowledge, this joint
pattern is a unique presentation of
adolescent HV and has not been reported
in the literature.

Figure 2. AP bilateral radiograph of hallux valgus deformity showing unique cone-in-cup
MTP joint deformity.
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As the patient was asymptomatic
and experiencing no pain, conservative

treatment of observation and follow up
were arranged.

Figure 3. Oblique view of bilateral radiograph of hallux valgus deformity showing
unique cone-in-cup MTP joint deformity.
metatarsophalangeal (MTP) joint or the
first ray. It has been proposed that HV is
Discussion
caused by poor footwear. Footwear is
Adolescent
hallux
valgus,
thought to be an aggravating factor
associated with a bunion, is a lateral
rather than a causal factor as not all
deviation of the great toe in the
individuals who wear poor footwear go
transverse plane of the MTP joint. It
on to develop HV.2
generally affects females twice as often
Adolescent HV can be a serious
as males, and incidence varies depending
on the population being studied and
finding as it can indicate fibrodysplasia
1
ossificans progressiva (FOP), when
cultural practices, such as footwear use.
HV has a multifactorial etiology
found in combination with short thumbs.
including causes such as inflammatory
FOP is a very rare yet deleterious
joint disease, genetic predisposition,
genetic disease characterized by
abnormal mechanics or anatomy of the
extraskeletal bone formation. Pressure
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on soft tissue causes new born formation
and can lead to a ‘stone statue’ disease,
where an individual slowly loses muscle
function and freezes into one position.3,4
Adolescent HV is thought to be
caused by metatarsus primus varus
(MPV). Taken together, HV and MPV
are the most common foot deformities in
adolescents.
As many as 50% of
adolescent HV patients will also have
flexible flat feet and ligamentous laxity.3
Diagnosis of HV can be made
from patient history and clinical
examination,
but
may
require
radiographic studies, especially to assess
the articulating surfaces of the MTP joint
and for surgical planning. Physical
findings associated with HV include
bursitis of the MTP joint covering,
synovitis of the MTP joint, hammertoe
deformity of the lesser toe, medial dorsal
cutaneous nerve entrapment also known
as Morton’s neuroma, callus formation
under the second metatarsal head due to
altered
weight-bearing
and
the
development of osteoarthritis of the
MTP joint.5,6,7
There are a number of
radiographic criteria used to assess the
degree of HV. First, the status and
condition of the articulating surfaces of
the MTP joint should be inspected.
Second, the HV angle, which is the
angle made between the articulating
surfaces of the metatarsal and the
proximal phalanx should be measured.
An angle greater than 20° is considered
abnormal. Thirdly, the intermetatarsal

(IMT) angle, which is the angle between
the first and second metatarsal bones
should normally be less than 9°.8
Multiple treatment options exist
for HV and choice depends on the
amount of discomfort expressed by the
patient, need for joint salvage and
physician preference. There is also great
debate on whether bilateral or unilateral
repair is best, and whether joint fusion or
bunion excision is best.9,10
Conclusion
We have presented a novel
description of an adolescent hallux
valgus in a 12 year old girl and review of
current hallux valgus literature.
Conservative management of HV
can include wearing of wide shoes,
stretching, icing after activity, and
NSAID medications. Foot orthoses have
been used to prevent joint dysfunction
and relieve pain. In one study of
rheumatoid arthritis (RA) patients,
orthoses were shown to prevent
progression of the hallux valgus angle in
90% of the treatment group vs. 75% of
the control group, however there was no
significant
difference
in
pain
11
experienced. Splinting is also used to
treat HV, most commonly non-weight
bearing night splints, however a clinical
trial that examined the effects of splints
on HV was not able to demonstrate any
improvements in reducing pain.12
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Surgical management is based
upon clinical and radiographic findings.
A surgeon must take into account a
patient’s level of pain and ability to
ambulate before they decide to proceed
with any surgery. There are well over
one hundred different operations
available to treat HV, but all procedures
include some combination of the
following. Arthrodesis is a surgery
where the MTP joint is fused resulting in
loss of ROM but also decrease in pain
symptoms. Osteotomy with distal soft
tissue correction, where the metatarsal
bone is cut and realigned, is the most
common surgical option. In some cases,
excision of the bunion with soft tissue
correction is the only operation
necessary. In rare cases, a primary joint
fusion of the MTP joint is required. In
adolescent hallux valgus, the periosteum
is very active and the osteotomies
remodel very well. The choice of
surgery depends on degree of angulation
on radiograph, the status of the
articulating surface and the patients’
symptomatology.
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Cavitating pulmonary lesions and hemoptysis in a case of
Wegener’s granulomatosis
Wang Xi, BMSc (Meds 2011) and Louise Moist, MSc, MD, FRCPC
Case
A 49-year old gentleman was
admitted for investigation of multiple
cavitating pulmonary lesions on CT and
hemoptysis (Figure 1)1. He developed a dry,
non-productive cough a month prior to
admission with fevers, chills, and night
sweats, but no shortness of breath and no
chest pain. Half a month prior to admission,
he was diagnosed with pneumonia by chest
X-ray and prescribed azithromycin. Without
symptomatic relief after one week on
antibiotics, his treatment regimen was
changed to gatifloxacin and metronidazole
for ten days. Three days later, the patient’s
symptoms worsened to include a productive
cough yielding yellow sputum, hemoptysis,
muscle aches, epistaxis, and hematuria. He
had also lost ten pounds the preceding
month. The patient was deteriorating which
prompted CT investigation showing multiple
cavitation lesions.
The patient had quit smoking three
years ago after a 30 pack-year history. He
had an unremarkable medical history, and
no family history of lung disease or
vasculitis. He had no known previous
exposures to farming, mining, or tending to
birds. He had no significant travel history or
exposure to tuberculosis.

Figure 1. Multiple,
bilateral
cavitating lesions on CT (adapted from
Harrison’s
Principles
of
Internal
1
Medicine) .
On examination, the patient had a
temperature of 38.9oC, a heart rate of 110
beats/min, blood pressure 127/72, and a
respiratory rate of 16/minute, saturating 9294% oxygen on room air. Examinations of
cardiovascular and pulmonary systems were
unremarkable. No finger clubbing was
present. His hemoglobin was low at 89 g/L
and creatinine high at 132 µmol/L.
Urinalysis was positive for blood and
protein, but negative for casts. Bacterial and
fungal cultures were requested, as well as an
initial vasculitis screen with serum ANA,
rheumatoid factor, C-ANCA, P-ANCA, C3,
C4, CH50, ESR, and CRP. The C-ANCA
titre (Proteinase 3, PR3) was positive at 154
(> 30), strongly suggesting a diagnosis of
Wegener’s granulomatosis (WG). He was
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started on pulse prednisone and oral
cyclophosphamide.
While in hospital, his renal function
declined, with his creatinine rising to over
600 µmol/L. A trial of plasma exchange was
initiated with five treatments over ten days.
Renal function improved and he was
fortunate to avoid hemodialysis. Hemoptysis
and hematuria improved with time. No renal
biopsy was performed. He was started on
oral Septra as prophylaxis against
Pneumocystis carinii pneumonia and also
given a no-salt-added diet. He was
discharged 1 month after admission after he
became stable. At discharge, his hemoglobin
was low at 93 g/L and creatinine high at 407
µmol/L. He was to be reassessed and
advised not to return to work.

Table 1. Common Clinical Findings of
Wegener’s Granulomatosis2
Systemic
Fever, lethargy, weakness,
weight loss, night sweats, skin
lesions (rash and skin sores),
arthralgias
Lungs
Pulmonary
infiltrates,
pulmonary
nodules,
hemoptysis, pleuritis
Kidney
Glomerulonephrtitis,
hematuria, proteinuria
Ear, Nose, Sinusitis, nasal membrane
Throat
ulceration and crusting, saddle
nose deformity, epistaxis,
hearing loss, ear pain, oral
lesions
Eyes
Conjunctivitis, eye pain, visual
loss
Nervous
Peripheral neuropathy
System

Discussion
WG is a systemic vasculitis that is
characterized by granulomatous lesions in
the upper and lower respiratory tracts and
focal necrotizing glomerulonephritis. All of
the body’s small and medium-sized vessels
can be affected resulting in many potential
clinical manifestations (Table 1)2. These
manifestations
may
suggest
several
vasculitic etiologies and diagnosis may
prove to be a challenge. In this case, a
common presentation of WG is discussed,
where a supposed pneumonia, as shown on
chest X-ray, does not resolve after treatment
with multiple antibiotics. Combined with
further symptoms and/or investigations, the
circumstances point toward an alternate
diagnosis (Table 2)3.

The serum auto-immune anti-nuclear
cytoplasmic antibody (ANCA) level is
useful in both diagnosis and understanding
the pathophysiology of WG. Patients with
active WG are seen to have an auto-immune,
antigen-dependent,
inflammatory
background, which is corroborated by CD4+
T cell and monocyte activation in active
disease. Next, neutrophils are activated
through the production of C-ANCA or PANCA by B-cells targeting either Proteinase
3 (PR3) or Myeloperoxidase (MPO),
respectively4. However, the ANCAs are
present in 85% of cases of active WG and
are not pathognomic for the disease. Other
ANCA-positive vasculitides are microscopic
polyangiitis (MPA, 70% positive) and
Churg-Strauss syndrome (50% positive)4.
WG is mostly C-ANCA positive while MPA
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is mostly P-ANCA positive, but this
differentiation is not clinically significant as
treatment for both conditions is similar.
Churg-Strauss presents a different clinical
picture and generally includes asthma in
95% of patients, among other atopic allergic
symptoms5.
Table 2. Typical Differential Diagnosis for
Hemoptysis with Cavitating Lung Lesions3
Neoplasms
Infectious
Tuberculosis
Histoplasmosis,
Aspergillosis,
or
Coccidiomycosis
Klebsiella or Staphylococcal pneumonia
Lung abcess
Septic emboli
Autoimmune
Wegener’s granulomatosis
Rheumatoid arthritis
Environmental exposures
Silica
The hypothetical etiology of WG is
attributed to combinations of infectious,
genetic, or environmental factors; however,
efforts in identifying specific factors have
proved to be difficult6. The disease is
equally distributed between men and
women, presenting most commonly among
the fourth and fifth decades of life7.
The initial presentation of WG may
be followed by an indolent, mild, or
aggressive illness. Serum ANCA levels are
seen to vary with the extent, severity, and
activity of the disease. A limited form of the
disease can restrict itself primarily to the
lungs and is less likely to be ANCA

positive, but this form may still eventually
progress to the kidneys8. Poorer survival is
associated with older age and the need for
dialysis9.
Treatment of WG has advanced
greatly since the disease was first described
in 1936, when 1-year mortality was 100%
with median survival of 5 months10, 11.
Treatment with corticosteroids in the 1960s
procured a median survival time of 8
months12. The most significant medical
breakthrough was the introduction of
cyclophosphamide in the early 1970s that
prolonged survival and relieved symptoms.
Overall, the treatment plan is twofold: to induce remission in patients with
active WG and to maintain remission once
the goal has been achieved. The strategy in
treating WG is primarily immune
suppression given the inflammatory nature
of the disease. Patient symptoms, disease
activity, organ involvement, and lab test
results are all determinants of a patient’s
particular treatment plan. In severe WG with
kidney involvement, cyclophosphamide and
prednisone are generally prescribed,
providing symptom relief in 91% of patients
and inducing remission in 75% of patients2.
Due to the immunosuppressive nature of
cyclophosphamide, it is preferred to switch
to methotrexate or azathioprine after three to
six months. Induction can be achieved in
patients with mild disease with methotrexate
and
prednisone.
During
treatment,
prophylactic therapy with Septra should be
used to prevent Pneumocystic carinii
pneumonia. Septra has also been associated
with a decreased recurrence of WG. The
UWOMJ 78(1) 2008 S35

presence of renal failure in a WG patient
increases the risk of end-stage renal disease
and mortality. For patients with creatinine
over 500 µmol/L, plasma exchange has been
shown to reduce this risk13.
Even with treatment, WG can recur
or maintain a low activity level in 60-80% of
patients, leading to organ damage and
chronic morbidity2, 14. Important risk factors
for relapse were C-ANCA positivity and
disease within the lower or upper respiratory
tracts15. Overall mortality for WG patients is
four times the rate of the mortality of the
general population16. Most (93%) of the
morbidity and mortality was due to diseaserelated activity rather than treatment-related
causes9.
Table 3. Key Points
• Wegener’s granulomatosis is a
complex vasculitis with many
potential systemic manifestations
• Suspect alternate etiologies in
suspected cases of pneumonia that
does not resolve with multiple
antibiotics
• Goals of management are induction
and maintenance of remission
• The patient on immunosuppressants
for WG should be given prophylaxis
and be vigilant for infections
• Reduce cardiac risk factors as
vasculitic diseases increase the risk
of an adverse cardiovascular event
Conclusion
WG is a systemic vasculitis with
many potential clinical manifestations and is

challenging to manage in the clinic. The
diagnosis of WG has potentially devastating
impacts on patients’ lives given the high
risks of organ damage and recurrence of the
disease. Treatment of WG reduces mortality
and morbidity but does not eliminate these
risks altogether. Consequently, patients
should be given regular follow-up to
monitor disease remission and organ
function.
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